Gate Bioscience
PrivateLast Round
Series B
Nov 13, 2025
Est. Valuation
$161M
Total Funding Raised
$135M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gate Bioscience is a biotechnology company that develops small molecule drugs known as Molecular Gates to selectively eliminate disease-causing extracellular proteins at their source within cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate Bioscience Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Gate Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 13, 2025 | ||||
| Series A | Nov 1, 2023 |
Key People
Founding team and executive leadership
Gate Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed, Series B, Series A |
| GV | Series A, Series B |
| Forbion | Series B |
| ARCH Venture Partners | Series A, Series B |
| ARCH Venture Partners | Series A, Series B |
| Versant Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
$65M round completed.
- Nov 13, 2025
Vanessa Carle joins the board in connection with recent financing.
Gate Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gate Bioscience's valuation, stock price, and market status.